The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation

Hepatology

Volumn 28, Issue 3, 1998, Pages 831-838

  Sheiner, Patricia A ^a,d   Boros, Peter ^a   Klion, Franklin M ^a   Thung, Swan N ^a   Schluger, Leona Kim ^a   Lau, Johnson Y N ^b   Mor, Eytan ^c   Bodian, Carol ^d   Guy, Stephen R ^a   Schwartz, Myron E ^a   Emre, Sukru ^a   Bodenheimer Jr , Henry C ^a   Miller, Charles M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c RABIN MEDICAL CENTER   (Israel)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT INDICATION; TREATMENT OUTCOME; VIREMIA; VIRUS DETECTION;

EID: 17344367725     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280334     Document Type: Article

References (28)

1. Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States: recipient characteristics and outcome. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1995. Los Angeles CA: UCLA Tissue Typing Laboratory, 1996:19-34.
2. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
3. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-819.
4. Johnson MW, Washburn K, Freeman RB, FitzMaurice SE, Dienstag J, Basgoz N, Jenkins RL, et al. Hepatitis C viral infection in liver transplantation. Arch Surg 1996;131:284-291.
5. Schluger LK, Sheiner PA, Thung SN, Min A, Wolf D, Fiel I, Zhang D, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. HEPATOLOGY 1996;23:971-976.
6. Gane EJ, Naoumov NV, Qian K, Mondelli MU, Maertens G, Portmann BC, Lau JY, et al. A longitudinal analysis of hepatitis C virus replication after liver transplantation. Gastroenterology 1996;110:167-177.
7. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-999.
8. Lau JY, Davis GL, Brunson ME, Qian KP, Lin HJ, Quan SM, DiNello R, et al. Hepatitis C virus infection in kidney transplant recipients. HEPATOLOGY 1993;18:1027-1031.
9. Wright TL, Combs C, Kim M, Ferell L, Bacchetti P, Ascher N, Roberts J, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. HEPATOLOGY 1994;20:773-779.
10. Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynes M, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. HEPATOLOGY 1995;22:1084-1089.
11. Lau JY, Davis GI, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-1504.
12. Lau JY, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995;171:281-289.
13. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechet C, Brouwer JT, et al. A proposed system for the nomenclature of hepatitis C viral genotypes [Letter]. HEPATOLOGY 1994;19:1321-1324.
14. DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
15. Kiysawa K, Akahane Y, Nagata A, Koike Y, Furuta S. The significance of blood transfusion in non-A, non-B chronic liver disease in Japan. Vox Sang 1982;43:45-52.
16. Greenson JK, Svoboda-Newman SM, Merion RM, Frank TS. Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol 1996;20:731-738.
17. Sheiner PA, Schluger LK, Emre S, Thung S, Lau YN, Guy SR, Schwartz ME, et al. Retransplantation for recurrent hepatitis C. Liver Transplant Surg 1997:3:130-136.
18. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. The course of hepatitis C virus infection after liver transplantation. HEPATOLOGY 1994;20:1137-1143.
19. Balkwill FR. Interferons. Lancet 1989;1:1060-1063.
20. Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, et al. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. HEPATOLOGY 1995;22: 1351-1354.
21. Reddy KR, Weppler D, Zervos XA, Nery JR, Webb MG, Khan MF, Gavlik A, et al. Recurrent HCV infection following OLTx: The role of early post OLTx interferon treatment [Abstract]. HEPATOLOGY 1996;24:295A.
22. Cacciarelli TV, Martinez OM, Gish RG, Villaneuva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: preand posttreatment with interferon alfa. HEPATOLOGY 1996;24:6-9.
23. Hakozaki Y, Shirahama T, Katou M, Nakagaw K, Oba K, Yoshii O, Matsumoto T, et al. Long-term prognosis of chronic hepatitis C after treatment with interferon alpha-2b and characterization of incomplete responders. Am J Gastroenterol 1996;91:2145-2149.
24. Wright HI, Gavaler JS, Van Theil DH. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992;53:121-124.
25. Schiffman ML, Hofmann CM, Luketic VAC, Sanyal AJ, Contos MJ, Mills AS. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose. HEPATOLOGY 1996;24: 21-26.
26. Feray C, Gigou M, Samuel D, Paradis V, Mshiro S, Maertens G, Reynes M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-1096.
27. Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB Jr, Wiesner R, et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997;63:1419-1423.
28. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, et al. Severe or multiple rejection episodes lead to increased early recurrence of hepatitis C after orthotopic liver transplantation. HEPATOLOGY 1995;21:30-34.